Sale of fake obesity drugs driven by high prices, weight-loss desire prompts health concern
Ozempic and Mounjaro are brand names of the ‘GLP-1 receptor agonist’ class of medicines, which help one manage diabetes and obesity by targeting appetite and enhancing satiety, resulting in a…
Dr Reddy’s set to start selling generic Ozempic in India at potentially half price
The prices of Ozempic in India can potentially halve to ₹3,600 after Dr. Reddy’s and its ilk start producing the generic version of semaglutide, Nomura says. Dr Reddy’s Laboratories Ltd. is…
Weight loss drug ‘Ozempic’ approved for use in India: What we need to know about its health benefits and risks
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug…
Eye stroke alert: Ozempic linked to rare vision-loss condition
If you’re on Ozempic or Wegovy to manage type 2 diabetes—or to shed some pounds—there’s something new you should have on your radar. Doctors are now flagging a rare but…
Novo Nordisk to phase out country’s largest insulin brand
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human Mixtard, among other older insulin brands in India. Human Mixtard…
